Shamburg News · 8-K filed Nov 12, 2026, 4:08 PM EST

STERIS Irish FinCo prices $1.5 billion of senior notes to help fund Xodus Medical acquisition

STE · STERIS plc

  • Financing
  • Acquisition
  • Material agreement
  • Materiality: high

On November 9, 2026, STERIS Irish FinCo Unlimited Company, a wholly-owned subsidiary of STERIS plc, priced $1.5 billion of senior notes, split into $750 million of 5.650% notes due 2033 and $750 million of 5.875% notes due 2036. The notes are guaranteed by STERIS plc, STERIS Corporation and STERIS Limited, and the offering is expected to close on or about November 24, 2026. Net proceeds, together with a delayed draw term loan and cash on hand, are intended to fund the purchase price of the pending acquisition of Xodus Medical, Inc. and related entities, along with expenses and working capital.

Read the filing on EDGAR ↗

Source: SEC EDGAR, Form 8-K, Item 8.01, accession 0001193125-26-458364.

Written from the filing by Shamburg Markets. Figures are as reported by the company.